Global Genetic Toxicology Testing Market Report to 2030

DublinAnd January 20, 2023 /PRNewswire/ – “Genetic Toxicology Testing Market Share, Size, Trends, Industry Analysis Report, By Type, By Product, By Application, By Region, Segment Forecast, 2022 – 2030” has been added to an offer.

Research and Markets logo

Research and Markets logo

The global genetic toxicology test market size is projected to grow 3.21 billion US dollars by 2030, according to a new study. This report provides an insight into the current market dynamics and provides an analysis of future market growth.

Genotoxin testing is an in-depth study of the pharmaceutical and biotech sector where harmful substances in the body are detected and removed. Moreover, increasing research and development activities, pharmaceuticals and opposition to animal testing are the factors that contribute to the growth of the industry.

In addition to this, the elderly population is increasing across countries such as IndiaAnd JapanAnd BrazilAnd MexicoAnd China It is likely to have a positive impact on the demand for genotoxic testing during the forecast period. Several government initiatives and investments have led to increased development activities in the pharmaceutical sector.

The market was positively impacted during the COVID-19 pandemic due to increased testing for SARS-CoV-2. The FDA has approved several toxicology kits during COVID-19 emergencies, such as in vitro toxicology assays and consumables. With COVID-19, there has been an increase in characterization studies, COVID-19 testing, and healthcare awareness among people.

Highlights of the Genetic Toxicology Testing market report:

  • The in vitro and in vivo segment of the market is expected to grow due to the increasing focus on personalized drugs and pharmacokinetics.

  • The services sector accounted for the highest share of revenues in 2021 and is expected to continue its dominance due to increased research and development activities in the pharmaceutical sector and increased interest in omics studies.

  • The cosmetics industry is expected to grow during the forecast period due to the increase in the consumption of cosmetics by people.

  • Asia Pacific It is expected to grow at a significant CAGR during the forecast period due to increased government investment, research and development progress, and technological advancement in the region, such as India And China.

  • Some of the major players operating in the industry are Thermo Fisher Scientific, Inc. Charles River Laboratories International, Eurofins Scientific, Merck KGAA, Jubilant Life Sciences Ltd, Laboratory Corp of America Holdings, Gentronix Ltd, and Creative Bioarray.

Main topics covered:

1 Introduction

2. Executive summary

3. Research methodology

4. Insights on the global genetic toxicology testing market
4.1 Genetic Toxicology Testing – Industry Profile
4.2 Dynamics of the Genetic Toxicology Testing Market
4.2.1. drivers and opportunities Increasing the number of pharmaceutical research and development activities Growing global demand for humanized animal models
4.2.2. Limitations and challenges Countries’ reluctance to replace in vivo methods with an alternative test
4.3 Porter’s Five Forces Analysis
4.3.1. Bargaining power of suppliers (moderate)
4.3.2. Newcomer Threats: (Low)
4.3.3. Buyers’ bargaining power (moderate)
4.3.4. Alternative threat (moderate)
4.3.5. Competition between established companies (high)
4.4 PESTEL analysis
4.5 Genetic Toxicology Testing Industry Trends
4.6 Value Chain Analysis
4.7 Analysis of the impact of COVID-19

5. Global Toxicology Testing Market, by Type
5.1 Main Findings
5.2 Introduction
5.2.1. Global Genetic Toxicology Testing Market, by Type, 2018-2030 (Billion USD)
5.3 In vitro
5.3.1. Global Genetic Toxicology Testing Market, In Vitro, by Region, 2018-2030 (Billion USD)
5.4. in vivo
5.4.1. Global Genetic Toxicology Testing Market, by Vivo, by Region, 2018-2030 (Billion USD)

6. Global Toxicology Testing Market, by Product
6.1 Main Findings
6.2 Introduction
6.2.1. Global Genetic Toxicology Testing Market, by Product, 2018-2030 (Billion USD)
6.3 Reagents and consumables
6.3.1. Global Genetic Toxicology Testing Market, by Reagents and Consumables, by Region, 2018-2030 (Billion USD)
6.4. scales
6.4.1. Global Genetic Toxicology Testing Market, by Assays, by Region, 2018-2030 (Billion USD)
6.5. services
6.5.1. Global Genetic Toxicology Testing Market, by Services, by Region, 2018-2030 (Billion USD)

7. Global Toxicology Testing Market, by Application
7.1 Main Findings
7.2 Introduction
7.2.1. Global Genetic Toxicology Testing Market, by Application, 2018-2030 (Billion USD)
7.3. healthcare sector
7.3.1. Global Genetic Toxicology Testing Market, by Hospital Industry, by Region, 2018-2030 (Billion USD)
7.4. Food Industry
7.4.1. Global Genetic Toxicology Testing Market, by Food Industry, by Region, 2018-2030 (Billion USD)
7.5 Cosmetics industry
7.5.1. Global Genetic Toxicology Testing Market, by Cosmetics Industry, by Region, 2018-2030 (Billion USD)
7.6. Agriculture industry
7.6.1. Global Genetic Toxicology Testing Market, by Agricultural Industry, by Region, 2018-2030 (Billion USD)
7.7 et al
7.7.1. Global Other Genotoxin Testing Market, by Region, 2018-2030 (Billion USD)

8. Global Toxicology Testing Market, by Geography

9. The competitive landscape
9.1 Expansion and Acquisition Analysis
9.1.1. expansion
9.1.2. acquisitions
9.2. Partnerships / collaborations / agreements / exhibitions

10. Company profiles
10.1. Thermo Fisher Scientific Inc
10.1.1. Company profile
10.1.2. Financial performance
10.1.3. Product measurement
10.1.4. New developments
10.2. Charles River International Laboratories
10.2.1. Company profile
10.2.2. Financial performance
10.2.3. Product measurement
10.2.4. New developments
10.3. Scientific Eurofins
10.3.1. Company profile
10.3.2. Financial performance
10.3.3. Product measurement
10.3.4. New developments
10.4. Merck CJA
10.4.1. Company profile
10.4.2. Financial performance
10.4.3. Product measurement
10.4.4. New developments
10.5. Jubilant Life Sciences Ltd
10.5.1. Company profile
10.5.2. Financial performance
10.5.3. Product measurement
10.5.4. New developments
10.6. Corp of America Holdings Lab
10.6.1. Company profile
10.6.2. Financial performance
10.6.3. Product measurement
10.6.4. New developments
10.7. Generonics Ltd
10.7.1. Company profile
10.7.2. Financial performance
10.7.3. Product measurement
10.7.4. New developments
10.8. Bioarray Creative
10.8.1. Company profile
10.8.2. Financial performance
10.8.3. Product measurement
10.8.4. New developments
10.9. MB Research Laboratories
10.9.1. Company profile
10.9.2. Financial performance
10.9.3. Product measurement
10.9.4. New developments
10.10. Sutera Health LLC
10.10.1. Company profile
10.10.2. Financial performance
10.10.3. Product measurement
10.10.4. New developments
10.11. Environmental Biological Detection Products Corporation
10.11.1. Company profile
10.11.2. Financial performance
10.11.3. Product measurement
10.11.4. New developments
10.12. Cyprotex plc
10.12.1. Company profile
10.12.2. Financial performance
10.12.3. Product measurement
10.12.4. New developments
10.13. Shanghai Medisilon Corporation
10.13.1. Company profile
10.13.2. Financial performance
10.13.3. Product measurement
10.13.4. New developments
10.14. Toxicon Corporation
10.14.1. Company profile
10.14.2. Financial performance
10.14.3. Product measurement
10.14.4. New developments
10.15. concave
10.15.1. Company profile
10.15.2. Financial performance
10.15.3. Product measurement
10.15.4. New developments
10.16. Bio Reliance
10.16.1. Company profile
10.16.2. Financial performance
10.16.3. Product measurement
10.16.4. New developments
10.17. Fraunhofer element
10.17.1. Company profile
10.17.2. Financial performance
10.17.3. Product measurement
10.17.4. New developments
10.18. instim
10.18.1. Company profile
10.18.2. Financial performance
10.18.3. Product measurement
10.18.4. New developments
10.19. Generonics Ltd
10.19.1. Company profile
10.19.2. Financial performance
10.19.3. Product measurement
10.19.4. New developments
10.20. Toxicon Corporation
10.20.1. Company profile
10.20.2. Financial performance
10.20.3. Product measurement
10.20.4. New developments

For more information on this report, visit

Media contact:

Research and markets
Laura Woodmentor manager

For EST office hours, call +1-917-300-0470
For US/Canada, call toll-free at +1-800-526-8630
For GMT office hours, call +353-1-416-8900

US fax: 646-607-1907
Fax (outside the US): +353-1-481-1716




View original content: growth301726681.html

SOURCE Research and Markets

Leave a Comment